BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19066493)

  • 1. Survival and prognostic factor analysis in patients with metastatic pancreatic endocrine carcinomas.
    Strosberg J; Gardner N; Kvols L
    Pancreas; 2009 Apr; 38(3):255-8. PubMed ID: 19066493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic head carcinoma: clinical analysis of 189 cases.
    Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.
    Ekeblad S; Skogseid B; Dunder K; Oberg K; Eriksson B
    Clin Cancer Res; 2008 Dec; 14(23):7798-803. PubMed ID: 19047107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
    Lepage C; Rachet B; Coleman MP
    Gastroenterology; 2007 Mar; 132(3):899-904. PubMed ID: 17383419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
    Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
    Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of pancreatic endocrine neoplasms.
    Gomez-Rivera F; Stewart AE; Arnoletti JP; Vickers S; Bland KI; Heslin MJ
    Am J Surg; 2007 Apr; 193(4):460-5. PubMed ID: 17368289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
    Ferrone CR; Tang LH; Tomlinson J; Gonen M; Hochwald SN; Brennan MF; Klimstra DS; Allen PJ
    J Clin Oncol; 2007 Dec; 25(35):5609-15. PubMed ID: 18065733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.
    Fjallskog ML; Janson ET; Falkmer UG; Vatn MH; Oberg KE; Eriksson BK
    Neuroendocrinology; 2008; 88(1):53-8. PubMed ID: 18285678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
    Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
    Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.
    You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW
    Eur J Surg Oncol; 2009 Jul; 35(7):728-33. PubMed ID: 19188040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine tumors of the ileum: factors correlated with survival.
    Tomassetti P; Campana D; Piscitelli L; Casadei R; Nori F; Brocchi E; Santini D; Pezzilli R; Corinaldesi R
    Neuroendocrinology; 2006; 83(5-6):380-6. PubMed ID: 17016032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
    Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.